| Source Date | Board Meeting Date | Details |
|
14-Jul-2025
|
25-Jul-2025
|
Quarterly Results
|
|
16-May-2025
|
16-May-2025
|
Final Dividend
|
|
12-May-2025
|
16-May-2025
|
Final Dividend & Audited Results
|
|
06-Jan-2025
|
17-Jan-2025
|
Quarterly Results
|
|
15-Oct-2024
|
30-Oct-2024
|
Quarterly Results
|
|
22-Jul-2024
|
30-Jul-2024
|
Quarterly Results
|
|
08-May-2024
|
08-May-2024
|
Final Dividend(Cancelled)
|
|
23-Apr-2024
|
08-May-2024
|
Final Dividend & Audited Results
|
|
12-Jan-2024
|
25-Jan-2024
|
Quarterly Results
|
|
17-Oct-2023
|
26-Oct-2023
|
Quarterly Results
|
|
18-Jul-2023
|
27-Jul-2023
|
Quarterly Results
|
|
04-May-2023
|
17-May-2023
|
Final Dividend & Audited Results
|
|
16-Jan-2023
|
27-Jan-2023
|
Rights Issue & Quarterly Results Inter alia, to consider proposal of fund raising by way of equity shares or other securities through rights issue as may be permitted under applicable law, subject to such regulatory/statutory approvals as may be required including shareholders? approval, if applicable.
|
|
21-Oct-2022
|
04-Nov-2022
|
Quarterly Results
|
|
15-Jul-2022
|
25-Jul-2022
|
Quarterly Results
|
|
19-Apr-2022
|
28-Apr-2022
|
Audited Results & Final Dividend Inter alia, to consider: 1. Recommend final dividend, if any, for the Financial Year ended March 31, 2022 2. Consider approval of raising of funds by issue of equity shares or any other securities convertible into equity shares or a combination of such securities by way of further public offer, rights issue, American Depository Receipts/Global Depository Receipts/Foreign Currency Convertible Bonds, qualified institutions placement, preferential issue or any other method as may be permitted under applicable laws, subject to such regulatory/statutory approvals as may be required, including approval of the notice for the general meeting for obtaining the shareholders? approval in this regard.
|
|
10-Jan-2022
|
19-Jan-2022
|
Quarterly Results
|
|
13-Oct-2021
|
21-Oct-2021
|
Quarterly Results
|
|
14-Jul-2021
|
22-Jul-2021
|
Quarterly Results Inter alia, to: 1. Consider Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2021. 2. Consider approval of raising of funds by issue of equity shares or any other securities convertible into equity shares or a combination of such securities by way of further public offer, rights issue, American Depository Receipts/Global Depository Receipts/Foreign Currency Convertible Bonds, qualified institutions placement, preferential issue or any other method as may be permitted under applicable laws, subject to such regulatory/statutory approvals as may be required, including approval of the notice for the general meeting for obtaining the shareholders’ approval in this regard.
|
|
20-Apr-2021
|
29-Apr-2021
|
Final Dividend & Audited Results
|